Europe Chronic Cough Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Chronic Cough Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Chronic Cough Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Chronic Cough Market Regional Analysis

6.2 Europe Chronic Cough Market Revenue 2017-2027 (US$ Million)

6.3 Europe Chronic Cough Market Forecast Analysis

7. Europe Chronic Cough Market Analysis – by Drug Class

7.1 Antihistamines

7.1.1 Overview
7.1.2 Antihistamines: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Corticosteroids

7.2.1 Overview
7.2.2 Corticosteroids: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Decongestants

7.3.1 Overview
7.3.2 Decongestants: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.4 Combination Drug

7.4.1 Overview
7.4.2 Combination Drug: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.5 Antibiotics

7.5.1 Overview
7.5.2 Antibiotics: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.6 Acid Blockers

7.6.1 Overview
7.6.2 Acid Blockers: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.7 Other Drug Class

7.7.1 Overview
7.7.2 Other Drug Class: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Europe Chronic Cough Market Analysis – by Route of Administration

8.1 Oral

8.1.1 Overview
8.1.2 Oral: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Injections

8.2.1 Overview
8.2.2 Injections: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Inhalation

8.3.1 Overview
8.3.2 Inhalation: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Other Route of Administration

8.4.1 Overview
8.4.2 Other Route of Administration: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Europe Chronic Cough Market Analysis – by Distribution Channel

9.1 Hospital Pharmacy

9.1.1 Overview
9.1.2 Hospital Pharmacy: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Online Pharmacy

9.2.1 Overview
9.2.2 Online Pharmacy: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Retail Pharmacy

9.3.1 Overview
9.3.2 Retail Pharmacy: Europe Chronic Cough Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Europe Chronic Cough Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Chronic Cough Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 Europe Chronic Cough Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 UK: Europe Chronic Cough Market Breakdown, by Drug Class
10.2.1.1.2 UK: Europe Chronic Cough Market Breakdown, by Route of Administration
10.2.1.1.3 UK: Europe Chronic Cough Market Breakdown, by Distribution Channel

10.2.1.2 Germany: Europe Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Germany: Europe Chronic Cough Market Breakdown, by Drug Class
10.2.1.2.2 Germany: Europe Chronic Cough Market Breakdown, by Route of Administration
10.2.1.2.3 Germany: Europe Chronic Cough Market Breakdown, by Distribution Channel

10.2.1.3 France: Europe Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 France: Europe Chronic Cough Market Breakdown, by Drug Class
10.2.1.3.2 France: Europe Chronic Cough Market Breakdown, by Route of Administration
10.2.1.3.3 France: Europe Chronic Cough Market Breakdown, by Distribution Channel

10.2.1.4 Russia: Europe Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.4.1 Russia: Europe Chronic Cough Market Breakdown, by Drug Class
10.2.1.4.2 Russia: Europe Chronic Cough Market Breakdown, by Route of Administration
10.2.1.4.3 Russia: Europe Chronic Cough Market Breakdown, by Distribution Channel

10.2.1.5 Italy: Europe Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.5.1 Italy: Europe Chronic Cough Market Breakdown, by Drug Class
10.2.1.5.2 Italy: Europe Chronic Cough Market Breakdown, by Route of Administration
10.2.1.5.3 Italy: Europe Chronic Cough Market Breakdown, by Distribution Channel

10.2.1.6 Rest of Europe: Europe Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Chronic Cough Market Breakdown, by Drug Class
10.2.1.6.2 Rest of Europe: Europe Chronic Cough Market Breakdown, by Route of Administration
10.2.1.6.3 Rest of Europe: Europe Chronic Cough Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Novartis AG

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Teva Pharmaceutical Industries Ltd

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 GlaxoSmithKline plc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Bayer AG

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Mylan N.V.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Amneal Pharmaceuticals, Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Cipla Inc.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Reckitt Benckiser Group plc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Sun Pharmaceutical Industries Ltd

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Aurobindo Pharma Ltd

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Chronic Cough Market